![Richard Scalzo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Scalzo
No open positions remaining
Net worth: 944 017 $ as of 30/08/2026
Profile
Richard William Scalzo is Chief Financial Officer at Crescent Biopharma, Inc. since 2025.
Formerly, Mr. Scalzo was Controller at Dyne Therapeutics, Inc. from 2019 to 2020, Chief Accounting Officer at Kaleido Biosciences, Inc. in 2019, Controller at X4 Pharmaceuticals, Inc. from 2016 to 2018, Controller at Astellas Institute for Regenerative Medicine in 2014.
Education includes an undergraduate degree from Boston College conferred in 2008 and an MBA from the University of Massachusetts conferred in 2016.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/03/2026 | 24,243 ( 0.01% ) | 616 499 $ | 30/08/2026 | |
0.05% | 15/09/2026 | 19,730 ( 0.05% ) | 327 518 $ | 30/08/2026 |
Richard Scalzo active positions
| Companies | Position | Start |
|---|
Former positions of Richard Scalzo
| Companies | Position | End |
|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 28/11/2019 |
| X4 PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 31/07/2018 |
| OCATA THERAPEUTICS INC | Comptroller/Controller/Auditor | 31/08/2014 |
| DYNE THERAPEUTICS, INC. | Director of Finance/CFO | - |
Training of Richard Scalzo
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
92
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Institute for Regenerative Medicine
 Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine | Health Technology |
Kaleido Biosciences, Inc.
 Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Dyne Therapeutics, Inc.
 Dyne Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat muscle diseases | Health Technology |
- Stock Market
- Insiders
- Richard Scalzo
